Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Effect of salmon calcitonin nasal spray on bone mass in patients with high turnover osteoporosis.

Literature DB >> 8461563

Effect of salmon calcitonin nasal spray on bone mass in patients with high turnover osteoporosis.

C Gennari¹, D Agnusdei, A Camporeale.

Abstract

Entities: Disease Species

Mesh：

Substances：

Year: 1993 PMID： 8461563 DOI： 10.1007/bf01621909

Source DB: PubMed Journal: Osteoporos Int ISSN： 0937-941X Impact factor: 4.507

× No keyword cloud information.

10 in total

1. A specific method for the analysis of hydroxyproline in tissues and urine.

Authors: D J PROCKOP; S UDENFRIEND
Journal: Anal Biochem Date: 1960-11 Impact factor: 3.365

2. Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical study.

Authors: G F Mazzuoli; M Passeri; C Gennari; S Minisola; R Antonelli; C Valtorta; E Palummeri; G F Cervellin; S Gonnelli; G Francini
Journal: Calcif Tissue Int Date: 1986-01 Impact factor: 4.333

3. Effects of porcine calcitonin on calcium metabolism in osteoporosis.

Authors: S H Cohn; W Dombrowski; W Hauser; J Klopper; H L Atkins
Journal: J Clin Endocrinol Metab Date: 1971-11 Impact factor: 5.958

4. Calcium metabolism and 47calcium kinetics before and after long-term thyrocalcitonin treatment in senile osteoporosis.

Authors: A Caniggia; C Gennari; M Bencini; L Cesari; G Borrello
Journal: Clin Sci Date: 1970-04 Impact factor: 6.124

5. Urinary 99m-Tc-diphosphonate excretion as a simple method to quantify bone metabolism.

Authors: L Hyldstrup; N Mogensen; G F Jensen; P McNair; I Transbøl
Journal: Scand J Clin Lab Invest Date: 1984-04 Impact factor: 1.713

6. Long-term calcitonin therapy in postmenopausal osteoporosis.

Authors: H E Gruber; J L Ivey; D J Baylink; M Matthews; W B Nelp; K Sisom; C H Chesnut
Journal: Metabolism Date: 1984-04 Impact factor: 8.694

7. Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment.

Authors: R Civitelli; S Gonnelli; F Zacchei; S Bigazzi; A Vattimo; L V Avioli; C Gennari
Journal: J Clin Invest Date: 1988-10 Impact factor: 14.808

8. Calcitonin treatment of post-menopausal osteoporosis. Evaluation of efficacy by principal components analysis.

Authors: G Milhaud; J N Talbot; G Coutris
Journal: Biomedicine Date: 1975-05

9. Postmenopausal osteoporosis. A heterogeneous disorder as assessed by histomorphometric analysis of Iliac crest bone from untreated patients.

Authors: M P Whyte; M A Bergfeld; W A Murphy; L V Avioli; S L Teitelbaum
Journal: Am J Med Date: 1982-02 Impact factor: 4.965

10. 1-Year controlled randomised trial of prevention of early postmenopausal bone loss by intranasal calcitonin.

Authors: J Y Reginster; D Denis; A Albert; R Deroisy; M P Lecart; M A Fontaine; P Lambelin; P Franchimont
Journal: Lancet Date: 1987-12-26 Impact factor: 79.321

10 in total

6 in total

Review 1. Intranasal salcatonin (salmon calcitonin). A review of its pharmacological properties and role in the management of postmenopausal osteoporosis.

Authors: G L Plosker; D McTavish
Journal: Drugs Aging Date: 1996-05 Impact factor: 3.923